US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CALCIMEDICA

1.60

-0.0500-3.03%

Post-market: 1.780.1800+11.25%19:51 EDT

Volume:21.83K

Turnover:35.19K

Market Cap:10.93M

PE:-0.24

High:1.70

Open:1.64

Low:1.58

Close:1.65

52wk High:36.00

52wk Low:1.58

Shares:6.83M

Float Shares:3.96M

Volume Ratio:0.62

T/O Rate:0.55%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-6.6528

EPS(LYR):-9.8500

ROE:-365.70%

ROA:-63.58%

PB:1.98

PE(LYR):-0.16

Loading ...

Overview Company News Filings

Press Release: CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Inc Expected to Post a Loss of 28 Cents a Share - Earnings Preview

CalciMedica announces FDA alignment on Phase 2b Auxora trial design

CalciMedica, FDA alignment de-risks regulatory path, says H.C. Wainwright

CalciMedica Reaches FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis

MT Newswires Live

CalciMedica - Expects Ind Submission for Cm5480 in Mid-2027

THOMSON REUTERS

CalciMedica Announces FDA Alignment on Phase 2B Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational Endpoints

THOMSON REUTERS

CalciMedica - Plans Phase 1B Trial for Auxora in Pah with Data Expected Mid-2027

THOMSON REUTERS

CalciMedica Inc: Continues to Advance Preparations for Phase 2B Trial

THOMSON REUTERS

CalciMedica - FDA Aligns on Phase 2B Primary Endpoint of New-Onset Severe Respiratory Failure

THOMSON REUTERS

Calcimedica - Prospectus Covers Resale of up to 56,020,287 Shares of Common Stock - SEC Filing

THOMSON REUTERS

Calcimedica Announces Annual Shareholder Meeting

Calcimedica Files Initial Beneficial Ownership Statement for Alafi Capital Co LLC

Calcimedica Files Form 3 Initial Beneficial Ownership Statement for Director Evgeny Zaytsev

CalciMedica Announces Board Expansion and Leadership Transition

Calcimedica Names Evgeny Zaytsev to Board as Director Expands to Eight Members

Calcimedica Director Fred A. Middleton Acquires 248,972 Common Shares Worth $200,000

CalciMedica Advances Auxora After Favorable FDA Safety Review

Analysts Offer Insights on Healthcare Companies: OnKure Therapeutics (OKUR) and CalciMedica (CALC)

CalciMedica Says Auxora Phase 2 Trial May Continue Dosing After FDA Review

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/CALC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CALC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CALC\",,,,,undefined,":{"symbol":"CALC","market":"US","secType":"STK","nameCN":"CALCIMEDICA","latestPrice":1.6,"timestamp":1790971200000,"preClose":1.65,"halted":0,"volume":21833,"hourTrading":{"tag":"盘后","latestPrice":1.78,"preClose":1.6,"latestTime":"19:51 EDT","volume":174,"amount":297.296,"timestamp":1790985117617,"change":0.18,"changeRate":0.1125,"amplitude":0.1125},"delay":0,"changeRate":-0.030303030303030196,"floatShares":3962980,"shares":6828300,"eps":-6.65276,"marketStatus":"Market Closed","change":-0.05,"latestTime":"10-02 16:00:00 EDT","open":1.64,"high":1.7,"low":1.58,"amount":35187.7614074,"amplitude":0.072727,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.65276,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":1.65,"preHourTrading":{"tag":"盘前","latestPrice":1.64,"preClose":1.65,"latestTime":"09:29 EDT","volume":2074,"amount":3353.6899396000003,"timestamp":1790947741103,"change":-0.01,"changeRate":-0.006061,"amplitude":0.127273},"postHourTrading":{"tag":"盘后","latestPrice":1.78,"preClose":1.6,"latestTime":"19:51 EDT","volume":174,"amount":297.296,"timestamp":1790985117617,"change":0.18,"changeRate":0.1125,"amplitude":0.1125},"volumeRatio":0.6211874605383574,"impliedVol":1.8027,"impliedVolPercentile":0.8992},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CALC\",,,,,undefined,":{"symbol":"CALC","floatShares":3962980,"roa":"-63.58%","roe":"-365.70%","lyrEps":-9.849995,"volumeRatio":0.6211874605383574,"shares":6828300,"dividePrice":0,"high":1.7,"amplitude":0.072727,"preClose":1.65,"low":1.58,"week52Low":1.58,"pbRate":"1.98","week52High":36,"institutionHeld":0,"latestPrice":1.6,"eps":-6.65276,"divideRate":0,"volume":21833,"delay":0,"ttmEps":-6.65276,"open":1.64,"prevYearClose":32.95,"prevWeekClose":1.75,"prevMonthClose":1.62,"prevQuarterClose":1.62,"fiveDayClose":1.75,"twentyDayClose":2.2,"sixtyDayClose":4.7495},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CALC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-31","symbol":"CALC","defaultRemindTime":1788183000000,"type":"split","dateTimestamp":1788148800000,"forFactor":5,"toFactor":1,"ratio":5},{"market":"US","date":"2026-08-11","symbol":"CALC","fiscalQuarterEnding":"2026/06","expectedEps":-0.33,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2026-05-12","symbol":"CALC","fiscalQuarterEnding":"2026/03","expectedEps":-0.28,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"pre","actualEps":-0.22},{"market":"US","date":"2026-03-03","symbol":"CALC","fiscalQuarterEnding":"2025/12","expectedEps":-0.55,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772514000000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2025-11-12","symbol":"CALC","fiscalQuarterEnding":"2025/09","expectedEps":-0.41,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.39}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CALC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CALC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.3333,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":3,"updateTime":1787198400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CALC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CALC","date":"2026-10-02","current":-0.240502,"percent":0.874251,"low":-4.525842,"twenty":-3.262809,"median":-1.921057,"eighty":-0.674366,"high":-0.276938,"avg":-1.962979,"sd":1.148032,"marketCap":11266681},"quantilePoints":[{"date":"2024-01-05","current":-0.71129,"twenty":-0.71129,"median":-0.71129,"eighty":-0.71129,"marketCap":20480891},{"date":"2024-01-12","current":-0.644854,"twenty":-0.706809,"median":-0.663373,"eighty":-0.661399,"marketCap":18567932},{"date":"2024-01-19","current":-0.842346,"twenty":-0.707705,"median":-0.673245,"eighty":-0.662978,"marketCap":24254510},{"date":"2024-01-26","current":-1.017241,"twenty":-1.012132,"median":-0.706809,"eighty":-0.663373,"marketCap":29290430},{"date":"2024-02-02","current":-2.31259,"twenty":-1.35801,"median":-0.893146,"eighty":-0.671271,"marketCap":66588713},{"date":"2024-02-09","current":-1.906022,"twenty":-2.088582,"median":-1.017241,"eighty":-0.673245,"marketCap":54881987},{"date":"2024-02-16","current":-1.682223,"twenty":-2.119115,"median":-1.116267,"eighty":-0.690619,"marketCap":48437918},{"date":"2024-02-23","current":-1.643058,"twenty":-2.095833,"median":-1.634666,"eighty":-0.702071,"marketCap":47310206},{"date":"2024-03-01","current":-1.633733,"twenty":-2.020905,"median":-1.643058,"eighty":-0.709498,"marketCap":47041703},{"date":"2024-03-08","current":-1.652383,"twenty":-1.962717,"median":-1.659843,"eighty":-0.789924,"marketCap":47578709},{"date":"2024-03-15","current":-1.626273,"twenty":-1.923926,"median":-1.652383,"eighty":-0.903305,"marketCap":46826901},{"date":"2024-03-22","current":-1.428584,"twenty":-1.903784,"median":-1.64026,"eighty":-0.984091,"marketCap":41134640},{"date":"2024-03-28","current":-1.309808,"twenty":-1.864992,"median":-1.631159,"eighty":-1.013409,"marketCap":45001081},{"date":"2024-04-05","current":-1.359825,"twenty":-1.759493,"median":-1.626273,"eighty":-1.046819,"marketCap":46719500},{"date":"2024-04-12","current":-1.378581,"twenty":-1.683991,"median":-1.551673,"eighty":-1.099979,"marketCap":47363907},{"date":"2024-04-19","current":-1.25354,"twenty":-1.680731,"median":-1.469614,"eighty":-1.115647,"marketCap":43067861},{"date":"2024-04-26","current":-1.653672,"twenty":-1.680731,"median":-1.452232,"eighty":-1.163031,"marketCap":56815208},{"date":"2024-05-03","current":-1.87562,"twenty":-1.717206,"median":-1.540483,"eighty":-1.238535,"marketCap":64440690},{"date":"2024-05-10","current":-1.766209,"twenty":-1.764959,"median":-1.622543,"eighty":-1.25479,"marketCap":60681649},{"date":"2024-05-17","current":-3.903797,"twenty":-1.803163,"median":-1.628585,"eighty":-1.259167,"marketCap":58318824},{"date":"2024-05-24","current":-3.709686,"twenty":-1.90453,"median":-1.64026,"eighty":-1.263536,"marketCap":55418993},{"date":"2024-05-31","current":-4.076341,"twenty":-2.061189,"median":-1.652383,"eighty":-1.269686,"marketCap":60896452},{"date":"2024-06-07","current":-3.763144,"twenty":-2.28275,"median":-1.667303,"eighty":-1.292545,"marketCap":56217609},{"date":"2024-06-14","current":-3.626433,"twenty":-2.775108,"median":-1.674763,"eighty":-1.30043,"marketCap":54175287},{"date":"2024-06-21","current":-3.741558,"twenty":-3.626433,"median":-1.678493,"eighty":-1.306682,"marketCap":55895138},{"date":"2024-06-28","current":-2.266521,"twenty":-3.626433,"median":-1.678493,"eighty":-1.308558,"marketCap":33859554},{"date":"2024-07-05","current":-3.0652,"twenty":-3.626433,"median":-1.678493,"eighty":-1.309808,"marketCap":45791016},{"date":"2024-07-12","current":-3.396184,"twenty":-3.511308,"median":-1.683696,"eighty":-1.342725,"marketCap":50735586},{"date":"2024-07-15","current":-3.518504,"twenty":-3.517065,"median":-1.685169,"eighty":-1.342739,"marketCap":52562927},{"date":"2024-08-02","current":-3.223823,"twenty":-3.515626,"median":-1.694429,"eighty":-1.342753,"marketCap":48160698},{"date":"2024-08-09","current":-3.346156,"twenty":-3.502674,"median":-1.717881,"eighty":-1.345855,"marketCap":49988225},{"date":"2024-08-16","current":-3.501123,"twenty":-3.583261,"median":-1.750157,"eighty":-1.351697,"marketCap":44075639},{"date":"2024-08-23","current":-3.569438,"twenty":-3.582315,"median":-1.766209,"eighty":-1.354811,"marketCap":44935652},{"date":"2024-08-30","current":-3.67191,"twenty":-3.613882,"median":-1.801693,"eighty":-1.356667,"marketCap":46225670},{"date":"2024-09-06","current":-4.397752,"twenty":-3.637946,"median":-1.869368,"eighty":-1.357299,"marketCap":55363303},{"date":"2024-09-13","current":-3.552359,"twenty":-3.65203,"median":-1.906022,"eighty":-1.362326,"marketCap":44720648},{"date":"2024-09-20","current":-3.53528,"twenty":-3.640824,"median":-2.030976,"eighty":-1.373579,"marketCap":44505645},{"date":"2024-09-27","current":-3.859775,"twenty":-3.700214,"median":-2.125233,"eighty":-1.378581,"marketCap":48590705},{"date":"2024-10-04","current":-3.740224,"twenty":-3.708962,"median":-2.289556,"eighty":-1.380457,"marketCap":47085683},{"date":"2024-10-11","current":-3.371069,"twenty":-3.708962,"median":-2.722888,"eighty":-1.392648,"marketCap":42438390},{"date":"2024-10-18","current":-3.381146,"twenty":-3.700214,"median":-2.935837,"eighty":-1.41484,"marketCap":42565242},{"date":"2024-10-25","current":-3.53528,"twenty":-3.675822,"median":-3.058004,"eighty":-1.429837,"marketCap":44505645},{"date":"2024-10-31","current":-4.098876,"twenty":-3.6768,"median":-3.0652,"eighty":-1.43485,"marketCap":51600748},{"date":"2024-11-08","current":-3.744979,"twenty":-3.72195,"median":-3.072551,"eighty":-1.469614,"marketCap":47145546},{"date":"2024-11-15","current":-3.340773,"twenty":-3.734279,"median":-3.223823,"eighty":-1.536753,"marketCap":45394425},{"date":"2024-11-22","current":-3.420079,"twenty":-3.72195,"median":-3.270562,"eighty":-1.540483,"marketCap":46472038},{"date":"2024-11-29","current":-3.423065,"twenty":-3.714694,"median":-3.298285,"eighty":-1.558387,"marketCap":46512613},{"date":"2024-12-06","current":-2.966657,"twenty":-3.710325,"median":-3.295449,"eighty":-1.607623,"marketCap":40310931},{"date":"2024-12-13","current":-2.768218,"twenty":-3.706791,"median":-3.249448,"eighty":-1.624781,"marketCap":37614548},{"date":"2024-12-20","current":-2.748374,"twenty":-3.682653,"median":-3.194715,"eighty":-1.626273,"marketCap":37344910},{"date":"2024-12-27","current":-2.986501,"twenty":-3.673866,"median":-3.079903,"eighty":-1.62766,"marketCap":40580570},{"date":"2025-01-03","current":-3.264315,"twenty":-3.665078,"median":-3.095642,"eighty":-1.630644,"marketCap":44355506},{"date":"2025-01-10","current":-2.976579,"twenty":-3.653123,"median":-3.165095,"eighty":-1.634479,"marketCap":40445751},{"date":"2025-01-17","current":-3.145251,"twenty":-3.645198,"median":-3.087772,"eighty":-1.638582,"marketCap":42737676},{"date":"2025-01-24","current":-2.867437,"twenty":-3.640824,"median":-3.065538,"eighty":-1.643058,"marketCap":38962740},{"date":"2025-01-31","current":-2.52017,"twenty":-3.640824,"median":-3.058004,"eighty":-1.652383,"marketCap":34244069},{"date":"2025-02-07","current":-2.688843,"twenty":-3.640824,"median":-3.04842,"eighty":-1.652383,"marketCap":36535995},{"date":"2025-02-14","current":-2.649155,"twenty":-3.63798,"median":-3.022334,"eighty":-1.653672,"marketCap":35996718},{"date":"2025-02-21","current":-2.420951,"twenty":-3.628742,"median":-2.996423,"eighty":-1.664577,"marketCap":32895877},{"date":"2025-02-28","current":-2.2622,"twenty":-3.626433,"median":-2.986501,"eighty":-1.670287,"marketCap":30738770},{"date":"2025-03-07","current":-2.182824,"twenty":-3.621826,"median":-2.966657,"eighty":-1.674017,"marketCap":29660217},{"date":"2025-03-14","current":-1.885166,"twenty":-3.613842,"median":-2.897203,"eighty":-1.674763,"marketCap":25615642},{"date":"2025-03-21","current":-2.083605,"twenty":-3.598472,"median":-2.84934,"eighty":-1.677747,"marketCap":28312025},{"date":"2025-03-28","current":-2.053839,"twenty":-3.588224,"median":-2.832711,"eighty":-1.678493,"marketCap":27907568},{"date":"2025-04-04","current":-1.800869,"twenty":-3.578114,"median":-2.788062,"eighty":-1.678493,"marketCap":24671908},{"date":"2025-04-11","current":-1.456441,"twenty":-3.570753,"median":-2.763257,"eighty":-1.678493,"marketCap":19953237},{"date":"2025-04-17","current":-1.515486,"twenty":-3.564314,"median":-2.743413,"eighty":-1.673271,"marketCap":20762152},{"date":"2025-04-25","current":-1.500724,"twenty":-3.555775,"median":-2.72853,"eighty":-1.652383,"marketCap":20559923},{"date":"2025-05-02","current":-1.525326,"twenty":-3.542112,"median":-2.713647,"eighty":-1.631674,"marketCap":20896971},{"date":"2025-05-09","current":-2.027208,"twenty":-3.53528,"median":-2.688843,"eighty":-1.635971,"marketCap":27772749},{"date":"2025-05-16","current":-1.385911,"twenty":-3.53528,"median":-2.683882,"eighty":-1.635971,"marketCap":26154918},{"date":"2025-05-23","current":-1.266008,"twenty":-3.530157,"median":-2.649155,"eighty":-1.623289,"marketCap":23892102},{"date":"2025-05-30","current":-1.292809,"twenty":-3.523446,"median":-2.629311,"eighty":-1.56753,"marketCap":24397888},{"date":"2025-06-06","current":-1.243723,"twenty":-3.518383,"median":-2.599038,"eighty":-1.538245,"marketCap":23471546},{"date":"2025-06-13","current":-1.295622,"twenty":-3.515866,"median":-2.540014,"eighty":-1.518241,"marketCap":24450982},{"date":"2025-06-20","current":-1.251201,"twenty":-3.512152,"median":-2.500326,"eighty":-1.501708,"marketCap":23612663},{"date":"2025-06-27","current":-1.058708,"twenty":-3.509535,"median":-2.41599,"eighty":-1.481761,"marketCap":19979945},{"date":"2025-07-03","current":-1.191972,"twenty":-3.502441,"median":-2.36638,"eighty":-1.456441,"marketCap":22494903},{"date":"2025-07-11","current":-1.199376,"twenty":-3.501123,"median":-2.291966,"eighty":-1.387959,"marketCap":22634623},{"date":"2025-07-18","current":-1.865696,"twenty":-3.489723,"median":-2.257239,"eighty":-1.411404,"marketCap":35209414},{"date":"2025-07-25","current":-2.731912,"twenty":-3.484044,"median":-2.266521,"eighty":-1.428584,"marketCap":51556643},{"date":"2025-08-01","current":-2.546823,"twenty":-3.475505,"median":-2.322122,"eighty":-1.43485,"marketCap":48063645},{"date":"2025-08-08","current":-2.154435,"twenty":-3.454157,"median":-2.266521,"eighty":-1.456441,"marketCap":40658490},{"date":"2025-08-15","current":-1.747024,"twenty":-3.441348,"median":-2.255181,"eighty":-1.469614,"marketCap":36467381},{"date":"2025-08-22","current":-1.867509,"twenty":-3.437078,"median":-2.222512,"eighty":-1.476122,"marketCap":38982373},{"date":"2025-08-29","current":-1.827347,"twenty":-3.425123,"median":-2.219309,"eighty":-1.480711,"marketCap":38144043},{"date":"2025-09-05","current":-2.121865,"twenty":-3.423477,"median":-2.192746,"eighty":-1.480711,"marketCap":44291801},{"date":"2025-09-12","current":-2.295898,"twenty":-3.423065,"median":-2.202668,"eighty":-1.484913,"marketCap":47924567},{"date":"2025-09-19","current":-2.148639,"twenty":-3.420676,"median":-2.179735,"eighty":-1.493836,"marketCap":44850688},{"date":"2025-09-26","current":-2.014767,"twenty":-3.420079,"median":-2.162026,"eighty":-1.495804,"marketCap":42056252},{"date":"2025-10-03","current":-2.041542,"twenty":-3.420079,"median":-2.153747,"eighty":-1.49974,"marketCap":42615139},{"date":"2025-10-10","current":-2.26243,"twenty":-3.414618,"median":-2.154435,"eighty":-1.504661,"marketCap":47225958},{"date":"2025-10-17","current":-2.175413,"twenty":-3.408403,"median":-2.154883,"eighty":-1.509581,"marketCap":45409575},{"date":"2025-10-24","current":-2.054929,"twenty":-3.404016,"median":-2.148639,"eighty":-1.514502,"marketCap":42894583},{"date":"2025-10-31","current":-2.00138,"twenty":-3.397592,"median":-2.141945,"eighty":-1.51728,"marketCap":41776809},{"date":"2025-11-07","current":-2.048235,"twenty":-3.391326,"median":-2.133215,"eighty":-1.521445,"marketCap":42754861},{"date":"2025-11-14","current":-2.162026,"twenty":-3.383731,"median":-2.134233,"eighty":-1.524736,"marketCap":45130131},{"date":"2025-11-21","current":-1.974579,"twenty":-3.381686,"median":-2.132574,"eighty":-1.525326,"marketCap":45533801},{"date":"2025-11-28","current":-2.668182,"twenty":-3.381573,"median":-2.133215,"eighty":-1.532182,"marketCap":61528270},{"date":"2025-12-05","current":-2.855642,"twenty":-3.381317,"median":-2.141945,"eighty":-1.538991,"marketCap":65851099},{"date":"2025-12-12","current":-2.868139,"twenty":-3.3751,"median":-2.148639,"eighty":-1.543198,"marketCap":66139288},{"date":"2025-12-19","current":-3.061848,"twenty":-3.367124,"median":-2.153747,"eighty":-1.550913,"marketCap":70606211},{"date":"2025-12-26","current":-3.880424,"twenty":-3.381573,"median":-2.158679,"eighty":-1.558055,"marketCap":89482566},{"date":"2026-01-02","current":-4.117873,"twenty":-3.39497,"median":-2.162708,"eighty":-1.565196,"marketCap":94958150},{"date":"2026-01-09","current":-3.330541,"twenty":-3.412041,"median":-2.175413,"eighty":-1.57623,"marketCap":76802267},{"date":"2026-01-16","current":-3.299297,"twenty":-3.419668,"median":-2.176029,"eighty":-1.587039,"marketCap":76081795},{"date":"2026-01-23","current":-3.336789,"twenty":-3.420079,"median":-2.182466,"eighty":-1.603069,"marketCap":76946361},{"date":"2026-01-30","current":-0.637364,"twenty":-3.420079,"median":-2.182824,"eighty":-1.583031,"marketCap":14697619},{"date":"2026-02-06","current":-0.381731,"twenty":-3.418022,"median":-2.176029,"eighty":-1.545008,"marketCap":8802721},{"date":"2026-02-13","current":-0.437407,"twenty":-3.413253,"median":-2.175413,"eighty":-1.525326,"marketCap":10086601},{"date":"2026-02-20","current":-0.325681,"twenty":-3.408403,"median":-2.163391,"eighty":-1.514502,"marketCap":7510195},{"date":"2026-02-27","current":-0.344926,"twenty":-3.404016,"median":-2.158679,"eighty":-1.495804,"marketCap":7954005},{"date":"2026-03-06","current":-0.352031,"twenty":-3.397592,"median":-2.153059,"eighty":-1.479793,"marketCap":10406728},{"date":"2026-03-13","current":-0.386648,"twenty":-3.391326,"median":-2.148639,"eighty":-1.433597,"marketCap":11430083},{"date":"2026-03-20","current":-0.392772,"twenty":-3.383731,"median":-2.141945,"eighty":-1.384445,"marketCap":11611138},{"date":"2026-03-27","current":-0.310224,"twenty":-3.381686,"median":-2.132894,"eighty":-1.376115,"marketCap":9170831},{"date":"2026-04-02","current":-0.313259,"twenty":-3.381573,"median":-2.123549,"eighty":-1.358562,"marketCap":9260571},{"date":"2026-04-10","current":-0.346705,"twenty":-3.381317,"median":-2.118518,"eighty":-1.347386,"marketCap":10249289},{"date":"2026-04-17","current":-0.324869,"twenty":-3.377027,"median":-2.107577,"eighty":-1.329678,"marketCap":9603788},{"date":"2026-04-24","current":-0.308892,"twenty":-3.372354,"median":-2.09509,"eighty":-1.301988,"marketCap":9131471},{"date":"2026-05-01","current":-0.314218,"twenty":-3.367124,"median":-2.089288,"eighty":-1.294497,"marketCap":9288910},{"date":"2026-05-08","current":-0.338397,"twenty":-3.363918,"median":-2.081703,"eighty":-1.271931,"marketCap":10003684},{"date":"2026-05-15","current":-0.547783,"twenty":-3.358987,"median":-2.071662,"eighty":-1.263846,"marketCap":10705862},{"date":"2026-05-22","current":-0.507504,"twenty":-3.352794,"median":-2.063761,"eighty":-1.252604,"marketCap":9918667},{"date":"2026-05-29","current":-0.700839,"twenty":-3.348874,"median":-2.061622,"eighty":-1.234608,"marketCap":13697206},{"date":"2026-06-05","current":-0.685212,"twenty":-3.344003,"median":-2.05537,"eighty":-1.209741,"marketCap":13391774},{"date":"2026-06-12","current":-0.718159,"twenty":-3.340014,"median":-2.053839,"eighty":-1.191972,"marketCap":14035701},{"date":"2026-06-18","current":-0.676673,"twenty":-3.338876,"median":-2.048235,"eighty":-1.178646,"marketCap":13224889},{"date":"2026-06-26","current":-0.506177,"twenty":-3.338459,"median":-2.042461,"eighty":-1.123522,"marketCap":9892727},{"date":"2026-07-02","current":-0.840665,"twenty":-3.336789,"median":-2.038195,"eighty":-1.058708,"marketCap":16429952},{"date":"2026-07-10","current":-0.767834,"twenty":-3.334606,"median":-2.033995,"eighty":-0.943945,"marketCap":15006549},{"date":"2026-07-17","current":-0.560982,"twenty":-3.330541,"median":-2.027681,"eighty":-0.832581,"marketCap":10963833},{"date":"2026-07-24","current":-0.578685,"twenty":-3.330337,"median":-2.021461,"eighty":-0.780363,"marketCap":11309810},{"date":"2026-07-31","current":-0.678998,"twenty":-3.322825,"median":-2.014767,"eighty":-0.764617,"marketCap":13270346},{"date":"2026-08-07","current":-0.575532,"twenty":-3.31233,"median":-2.00138,"eighty":-0.731949,"marketCap":11248198},{"date":"2026-08-14","current":-0.488891,"twenty":-3.302931,"median":-1.987993,"eighty":-0.705615,"marketCap":10384045},{"date":"2026-08-21","current":-0.937443,"twenty":-3.299662,"median":-1.98096,"eighty":-0.710394,"marketCap":19911299},{"date":"2026-08-28","current":-0.755484,"twenty":-3.296219,"median":-1.974579,"eighty":-0.716785,"marketCap":16046486},{"date":"2026-09-04","current":-0.707262,"twenty":-3.289202,"median":-1.971,"eighty":-0.705615,"marketCap":15022242},{"date":"2026-09-11","current":-0.681543,"twenty":-3.287136,"median":-1.968163,"eighty":-0.699873,"marketCap":14475979},{"date":"2026-09-18","current":-0.633321,"twenty":-3.273309,"median":-1.958322,"eighty":-0.689893,"marketCap":13451735},{"date":"2026-09-25","current":-0.55938,"twenty":-3.264315,"median":-1.949307,"eighty":-0.680525,"marketCap":11881228},{"date":"2026-10-02","current":-0.530446,"twenty":-3.262809,"median":-1.921057,"eighty":-0.674366,"marketCap":11266681}],"updateTime":1791035126281},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CALC\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658992331","title":"Press Release: CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992331","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992331?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446000,"startTime":"0","endTime":"0","summary":"CalciMedica announced a private placement of up to approximately. $49 million in gross proceeds, including approximately $15 million in. upfront gross proceeds. The proceeds are expected to support the. advancement of Auxora and CM5480 as part of the Company's pulmonary. -- Auxora Phase 1b proof-of-concept trial in PAH planned: CalciMedica plans. to evaluate Auxora in a Phase 1b trial in patients with pulmonary. arterial hypertension to generate initial clinical evidence regarding the. effects of CRAC channel inhibition on pulmonary vascular and right. -- CM5480 preclinical and IND-enabling studies advancing: Studies are. ongoing to further characterize the pharmacology, pharmacokinetics, and. safety profile of CM5480, CalciMedica's oral CRAC channel inhibitor. candidate for chronic use in PH. Preclinical data suggest CM5480 may be. differentiated by directly protecting right ventricular function, a key","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772923.USD","TM","LU0070302665.USD","LU0256863811.USD","CRAC","BK4006","BK4604","AP","PH","03160","BK4580","LU2264538146.SGD","BK4585","LU0417517546.SGD","BK4588","BK4555","LU1988902786.USD","BK4099","LU0211331839.USD","CALC","LU0320765489.SGD","BK4007","LU1989772840.SGD","LU1064131342.USD","LU0208291251.USD","LU0256863902.USD","BK4161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657472676","title":"CalciMedica Inc Expected to Post a Loss of 28 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657472676","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657472676?lang=en_us&edition=fundamental","pubTime":"2026-08-08 00:06","pubTimestamp":1786118764,"startTime":"0","endTime":"0","summary":"CalciMedica Inc <CALC.OQ> expected to post a loss of28cents a share - Earnings PreviewCalciMedica IncCALC.OQCALC.Ois expected to  show no change in quarterly revenue when it reports  results on August 10  for the period ending June 30 2026LSEG's mean analyst estimate for CalciMedica Inc is for a loss of 28 cents per share.The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 2 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for CalciMedica Inc is $10.50, about 1,374.7% above its last closing price of $0.71This summary was machine generated August 7 at 16:06 GMT.  All figures in US dollars unless otherwise stated.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N444210:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655899723","title":"CalciMedica announces FDA alignment on Phase 2b Auxora trial design","url":"https://stock-news.laohu8.com/highlight/detail?id=2655899723","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655899723?lang=en_us&edition=fundamental","pubTime":"2026-07-29 22:40","pubTimestamp":1785336017,"startTime":"0","endTime":"0","summary":"CalciMedica (CALC) announced that, following a Type C Focused Meeting, the U.S. Food and Drug Administration and the company have aligned on Phase ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-announces-fda-alignment-on-phase-2b-auxora-trial-design-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-announces-fda-alignment-on-phase-2b-auxora-trial-design-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","CALC","BK4007","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655753899","title":"CalciMedica, FDA alignment de-risks regulatory path, says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2655753899","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655753899?lang=en_us&edition=fundamental","pubTime":"2026-07-29 22:35","pubTimestamp":1785335738,"startTime":"0","endTime":"0","summary":"FDA alignment on CalciMedica’s (CALC) acute pancreatitis program for Auxora de-risks the regulatory path, validating Phase 2b endpoint selection an...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-fda-alignment-de-risks-regulatory-path-says-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-fda-alignment-de-risks-regulatory-path-says-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CALC","LABU","BK4007","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655189938","title":"CalciMedica Reaches FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2655189938","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655189938?lang=en_us&edition=fundamental","pubTime":"2026-07-29 22:08","pubTimestamp":1785334119,"startTime":"0","endTime":"0","summary":"CalciMedica (CALC) said Wednesday it has reached alignment with the US Food and Drug Administration on the endpoints and patient selection criteria for a planned phase 2b trial of Auxora in acute panc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","LABU","BK4588","BK4585","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655864895","title":"CalciMedica - Expects Ind Submission for Cm5480 in Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2655864895","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655864895?lang=en_us&edition=fundamental","pubTime":"2026-07-29 19:00","pubTimestamp":1785322803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA8QS6YS:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655864891","title":"CalciMedica Announces FDA Alignment on Phase 2B Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2655864891","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655864891?lang=en_us&edition=fundamental","pubTime":"2026-07-29 19:00","pubTimestamp":1785322803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA8QS6YS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655861038","title":"CalciMedica - Plans Phase 1B Trial for Auxora in Pah with Data Expected Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2655861038","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655861038?lang=en_us&edition=fundamental","pubTime":"2026-07-29 19:00","pubTimestamp":1785322803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA8QS6YS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655686485","title":"CalciMedica Inc: Continues to Advance Preparations for Phase 2B Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2655686485","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655686485?lang=en_us&edition=fundamental","pubTime":"2026-07-29 19:00","pubTimestamp":1785322803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA8QS6YS:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655610668","title":"CalciMedica - FDA Aligns on Phase 2B Primary Endpoint of New-Onset Severe Respiratory Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2655610668","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655610668?lang=en_us&edition=fundamental","pubTime":"2026-07-29 19:00","pubTimestamp":1785322803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA8QS6YS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654329540","title":"Calcimedica - Prospectus Covers Resale of up to 56,020,287 Shares of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2654329540","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654329540?lang=en_us&edition=fundamental","pubTime":"2026-07-25 04:13","pubTimestamp":1784924013,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nFWN43Q19G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651144483","title":"Calcimedica Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2651144483","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651144483?lang=en_us&edition=fundamental","pubTime":"2026-07-14 05:00","pubTimestamp":1783976402,"startTime":"0","endTime":"0","summary":"CalciMedica announces annual shareholder meetingCalciMedica will hold its annual stockholder meeting virtually on Aug. 19, 2026.Items include electing two Class III directors, approving changes to the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL1ry3Pd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650671130","title":"Calcimedica Files Initial Beneficial Ownership Statement for Alafi Capital Co LLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2650671130","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650671130?lang=en_us&edition=fundamental","pubTime":"2026-07-11 05:37","pubTimestamp":1783719424,"startTime":"0","endTime":"0","summary":"CalciMedica files initial beneficial ownership statement for Alafi Capital Co LLCCalciMedica Form 3 filing shows Alafi Capital Co LLC reported direct ownership of 5,112,345 common shares as of June 25","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDL6gmVYq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649593002","title":"Calcimedica Files Form 3 Initial Beneficial Ownership Statement for Director Evgeny Zaytsev","url":"https://stock-news.laohu8.com/highlight/detail?id=2649593002","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649593002?lang=en_us&edition=fundamental","pubTime":"2026-07-08 05:00","pubTimestamp":1783458006,"startTime":"0","endTime":"0","summary":"CalciMedica files Form 3 initial beneficial ownership statement for director Evgeny ZaytsevCalciMedica director Evgeny Zaytsev reported indirect ownership of 2.11 million common shares held by Bering Partners II.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CalciMedica Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL8JlZWV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649930231","title":"CalciMedica Announces Board Expansion and Leadership Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2649930231","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649930231?lang=en_us&edition=fundamental","pubTime":"2026-07-08 04:29","pubTimestamp":1783456195,"startTime":"0","endTime":"0","summary":"CalciMedica ( ($CALC) ) has provided an update. On July 2, 2026, CalciMedica’s board of directors expanded from seven to eight seats and appointed ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/calcimedica-announces-board-expansion-and-leadership-transition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/calcimedica-announces-board-expansion-and-leadership-transition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649937245","title":"Calcimedica Names Evgeny Zaytsev to Board as Director Expands to Eight Members","url":"https://stock-news.laohu8.com/highlight/detail?id=2649937245","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649937245?lang=en_us&edition=fundamental","pubTime":"2026-07-08 04:11","pubTimestamp":1783455063,"startTime":"0","endTime":"0","summary":"CalciMedica names Evgeny Zaytsev to board as director expands to eight membersCalciMedica expanded its board to eight directors, appointing Evgeny Zaytsev, M.D., Ph.D., as a Class I director effective","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDLbSGDSN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647743693","title":"Calcimedica Director Fred A. Middleton Acquires 248,972 Common Shares Worth $200,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2647743693","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647743693?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:46","pubTimestamp":1782737161,"startTime":"0","endTime":"0","summary":"CalciMedica director Fred A. Middleton acquires 248,972 common shares worth $200,000CalciMedica director Fred A. Middleton reported an indirect purchase of 248,972 common shares at $0.8 per share.Indi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL5NXlXN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Calcimedica Director Fred A. Middleton Acquires 248,972 Common Shares Worth $200,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646849099","title":"CalciMedica Advances Auxora After Favorable FDA Safety Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2646849099","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646849099?lang=en_us&edition=fundamental","pubTime":"2026-06-25 05:30","pubTimestamp":1782336609,"startTime":"0","endTime":"0","summary":"CalciMedica ( ($CALC) ) has issued an update. On June 23, 2026, CalciMedica entered into a securities purchase agreement for a private placement of...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/calcimedica-advances-auxora-after-favorable-fda-safety-review?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/calcimedica-advances-auxora-after-favorable-fda-safety-review?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4585","BK4588","LABU","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646817066","title":"Analysts Offer Insights on Healthcare Companies: OnKure Therapeutics (OKUR) and CalciMedica (CALC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2646817066","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646817066?lang=en_us&edition=fundamental","pubTime":"2026-06-25 01:40","pubTimestamp":1782322815,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on OnKure Therapeutics (OKUR) and CalciMedica (CALC). OnKure Therape...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-onkure-therapeutics-okur-and-calcimedica-calc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-onkure-therapeutics-okur-and-calcimedica-calc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4539","XLV","LABU","BK4581","BK4139","LU0029874061.USD","BK4585","BK4588","CALC","HCSG","BK4007","LU0128526141.USD","OKUR","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645890326","title":"CalciMedica Says Auxora Phase 2 Trial May Continue Dosing After FDA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2645890326","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645890326?lang=en_us&edition=fundamental","pubTime":"2026-06-24 19:47","pubTimestamp":1782301621,"startTime":"0","endTime":"0","summary":"CalciMedica (CALC) said Wednesday the US Food and Drug Administration completed its review of a protocol amendment and interim safety data from the phase 2 KOURAGE trial of Auxora without comments or ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","CALC","BK4007","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":62,"code":"91000000","status":"200"}]}}